NCT00427388View on ClinicalTrials.gov

Steroids In caRdiac Surgery Trial (SIRS Trial)

PHASE4UnknownINTERVENTIONAL
Enrollment

7,507

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

February 28, 2014

Study Completion Date

August 31, 2014

Conditions
Cardiac Surgical ProceduresCardiopulmonary BypassSystemic Inflammatory Response Syndrome
Interventions
DRUG

Methylprednisolone

Given by IV in 2 doses (250 mg each dose for a total of 500 mg)

OTHER

Placebo

Given in 2 IV doses (approximately 4 ml of 0.9% normal saline solution in each dose)

Trial Locations (1)

L8L 2X2

Hamilton General Hospital, Hamilton

Sponsors
All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

Population Health Research Institute

OTHER

NCT00427388 - Steroids In caRdiac Surgery Trial (SIRS Trial) | Biotech Hunter | Biotech Hunter